Giovanni Lauricella

Cellular Vehicles is building products to optimize the last mile cell therapy process.

Vonova is developing the less invasive pathway to the brain surface for the treatment of drug-resistant epilepsy and other neurological disorders. The novel system employs the latest in catheter-based technology to interface with the brain surface for diagnostic and therapeutic applications.

MedTech Startup is a community of entrepreneurs, investors, corporate strategics, service providers, and industry partners. Follow our content for insights on events, media, and opportunities.

Vivifi Medical has developed the first suture-less laparoscopic technology that enables connection of two vessels together for treatment of Varicocele & Mens Health Issues

The "SUTURE-TIGHT" tm catheter secures endovascular aortic repair grafts to the aorta at the time of initial implant or during repair procedures. (EVAR/TEVAR/TAVR) The "SUTURE-TIGHT" tm device is not commercially available.

Galen Robotics is developing a single-platform solution to aid surgeons across several disciplines with minimal disturbance to existing workflows. Our cooperative control paradigm aims to eliminate hand tremor and enable surgeons to realize precise minimally invasive interventions in otolaryngology, head and neck surgery, and tissue reconstruction that were previously considered beyond human capacity.

Windham Capital Partners is a New York City based growth equity firm focused on healthcare, with particular emphasis on therapeutic medical technology and digital health. We have a small, highly focused team of managers who enjoy close relationships with strategics, leading venture capital firms, and innovators and entrepreneurs in the healthcare industry.

HealthTech Capital is a group of private investors dedicated to funding and mentoring new “HealthTech” start ups at the intersection of healthcare and the computer/consumer electronic world. Our goal is to invest and mentor capital efficient companies that use new scalable business model to improve the efficiency of healthcare delivery from the hospital to the home. HealthTech is now an exploding healthcare market that leverages information technologies to decrease healthcare cost. Historically, venture funding has focused on “Efficacy” (therapeutics drugs and medical devices) and paid little attention to improving “Efficiencies” of healthcare delivery. Today, new paradigm shifting companies like Google, Microsoft, Intel, Apple, Amazon and others are turning their attention to HealthTech. HealthTech supports patient-centric healthcare and is distinct from Healthcare IT, enterprise backbone legacy information systems that are well served by existing major players. Our goal is to invest in capital efficient companies that use new business models to improve the efficiency of healthcare delivery.

Cellular Vehicles is building products to optimize the last mile cell therapy process.

Om Scandinavian Real Heart AB – Endast cirka 8 000 hjärttransplantationer sker årligen i hela världen och tillgången på donerade hjärtan är mycket begränsad. Behovet är stort och patienter med hjärtsvikt avlider i väntan på ett nytt hjärta. Scandinavian Real Heart AB utvecklar en hjärtpump (TAH) som efterliknar kroppens naturliga cirkulation och som ska kunna användas som en övergångslösning för patienter som väntar på en hjärttransplantation. Framgångsrika studier har genomförts på sövda djur och ytterligare djurstudier ska göras innan de första kliniska studierna i människa kan genomföras. Hjärtpumpens konstruktion och batterier ska ge patienten ökad rörlighet och möjlighet till högre livskvalité.

Vonova is developing the less invasive pathway to the brain surface for the treatment of drug-resistant epilepsy and other neurological disorders. The novel system employs the latest in catheter-based technology to interface with the brain surface for diagnostic and therapeutic applications.